bullish
2020 High Conviction: CJ Cheiljedang - Renewed Focus on Profits
503 Views17 Dec 2019 12:49
Cj Cheiljedang (097950 KS) (market cap of $3.2 billion) is a beneficiary of the company's renewed focus on improving profitability while reducing...
SUMMARY
(Sign Up to Access)Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
- Unlock all research summaries
- Follow top, independent analysts
- Receive personalised alerts and emails
- Access Briefings, Analytics, and Events
Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.
Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 16-minute read)
Discussions
(Paid Plans Only)
- Korean Value Stocks Portfolio Quarterly #2 (1Q 2020) & Thoughts of Warren Buffett's 2019 Results05 Jan 2020
- Review of Our M&A Research in 2019 & Korea M&A Market Outlook in 2020: What’s For Sale?19 Dec 2019
- Korea Shorts Data Analysis (#4): MOBIS, Celltrion, SEMCO, Fila Korea & LG Uplus18 Dec 2019
- 2020 High Conviction: CJ Cheiljedang - Renewed Focus on Profits17 Dec 2019
- CJ Group Chairman Lee Jae-Hyun Grants 122 Billion Won Worth of Stock to His 2 Children09 Dec 2019
- Korea M&A Spotlight: CJ Cheiljedang Is Close to Acquiring Schwan's (US) For US$2.8 Billion23 Jun 2018
- Korea Kolmar Consortium Named Preferred Bidder for CJ Healthcare - Biggest M&A Deal in Korea YTD20 Feb 2018
x